Expanded HPV Genotyping by Single-Tube Nested-Multiplex PCR May Explain HPV-Related Disease Recurrence
Authors:
- Luiz Ricardo GoulartLGLuiz Ricardo Goulart
- Bruna França Matias ColomboBCBruna França Matias Colombo
- Mayara Ingrid Sousa LimaMLMayara Ingrid Sousa Lima
- Maria Socorro A. de AndradeMAMaria Socorro A. de Andrade
- Juliana São JuliãoJJJuliana São Julião
- Adriana Freitas NevesAdriana Freitas Neves
- Silma Regina PereiraSPSilma Regina Pereira
Open Access
- 15 November 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (11) , 2326
Abstract
The role of the human papillomavirus (HPV) in the establishment of cervical cancer has driven studies to find more effective methods of viral detection so that early intervention strategies can be performed. However, the methods still have limitations, especially regarding detecting the different genotypes simultaneously. We have developed a high-throughput system using a single-tube nested-multiplex polymerase chain reaction (NMPCR) for the detection of 40 HPV genotypes using capillary electrophoresis. The NMPCR assay was compared to the Hybrid Capture 2 assay (HC2) with 40 women from the Northeast of Brazil (São Luis, MA), a high endemic region, where the HPV positivity was 75% and 37.5%, respectively. These results were validated by performing a molecular epidemiological study on 5223 Brazilian women undergoing gynecological examinations from 2009 to 2017, who presented with an HPV prevalence of 59%. Multiple infections were found in 62.5% and 58% of the patients from the endemic region and from the Brazilian women population, respectively, mostly presenting high-risk genotypes (90.5% and 60%, respectively). Considering cervical intraepithelial neoplasia and adenocarcinomas, the sensitivity and specificity were 97.5% and 100%, respectively. The NMPCR assay was also capable of identifying viral subtypes in cases of multiple infections, even with low viral loads (10−6 ng/µL of HPV DNA). The NMPCR test is a promising and robust tool for HPV diagnostics and a screening tool for prevention of cervical cancer.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado Minas Gerais (CBB-APQ-03613-17, CNPq 403193/2022-2)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CBB-APQ-03613-17, CNPq 403193/2022-2)
- BioGenetics Laboratories (CBB-APQ-03613-17, CNPq 403193/2022-2)
This publication has 52 references indexed in Scilit:
- Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancerMolecular Carcinogenesis, 2020
- The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese womenClinical Microbiology and Infection, 2018
- Screening for Cervical CancerJAMA, 2018
- Epidemiology and burden of HPV-related diseaseBest Practice & Research Clinical Obstetrics & Gynaecology, 2018
- Morphometric evaluation and nonclassical criteria for the diagnosis of HPV infection and cytological atypia in cervical samplesDiagnostic Cytopathology, 2013
- Human papillomavirus genotypes distribution in cervical samples from Uruguayan womenJournal of Medical Virology, 2013
- Prevalence of HPV infection by cervical cytologic status in BrazilInternational Journal of Gynecology & Obstetrics, 2009
- Prevalence of HPV Infection Among Females in the United StatesJAMA, 2007
- Detection and typing of human papillomavirus in cervical carcinomas in Russian womenCancer, 1999
- Human Pathogenic Papillomavirus Types: An Update1994